Terri B. Sebree
Overview
Terri B. Sebree received an average of $1M in total compensation, including $400K in salary, at Zynerba Pharmaceuticals from 2014 to 2022.
2022Zynerba PharmaceuticalsPresident
2021Zynerba PharmaceuticalsPresident
2020Zynerba PharmaceuticalsPresident
2019Zynerba PharmaceuticalsPresident
2018Zynerba PharmaceuticalsPresident
2017Zynerba PharmaceuticalsPresident
2016Zynerba PharmaceuticalsPresident
2015Zynerba PharmaceuticalsPresident
2014Zynerba PharmaceuticalsPresident
Source: SEC filings on April 21, 2023, April 25, 2022, April 21, 2021, April 23, 2020, April 25, 2019, April 23, 2018, and April 13, 2016.
Related executives
We found four more executives who work or worked at Zynerba Pharmaceuticals.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019